Literature DB >> 20404550

MicroRNAs in neurodegenerative disorders.

Eunsung Junn1, M Maral Mouradian.   

Abstract

MicroRNAs (miRNAs) are endogenous, small, noncoding RNAs regulating eukaryotic gene expression at the post-transcriptional level. During the last decade, considerable advances have been made in our understanding the biogenesis of miRNAs, the molecular mechanisms by which they regulate gene expression and their functional role in various physiological situations. miRNAs are abundant in the brain where they have crucial roles in development and synaptic plasticity. Accumulating evidence from postmortem brain analyses and animal model studies has begun to suggest that miRNA dysfunction contributes to neurodegenerative disorders. Here, we discuss several examples of investigations demonstrating the role of miRNAs in neurodegenerative disorders. As the expression of disease-causing genes is regulated by certain miRNA(s), changes in these miRNAs could lead to the accumulation of disease-causing proteins, and subsequently to neuronal dysfunction and death. Detailed understanding of these mechanisms can provide potential new therapeutic approaches to slow down or halt the progression of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404550     DOI: 10.4161/cc.9.9.11296

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.

Authors:  Anna B Glinskii; Shuang Ma; Jun Ma; Denise Grant; Chang-Uk Lim; Ian Guest; Stewart Sell; Ralph Buttyan; Gennadi V Glinsky
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

2.  Specification of neural cell fate and regulation of neural stem cell proliferation by microRNAs.

Authors:  Jacqueline T Pham; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2012-11-30

3.  Low-variance RNAs identify Parkinson's disease molecular signature in blood.

Authors:  Maria D Chikina; Christophe P Gerald; Xianting Li; Yongchao Ge; Hanna Pincas; Venugopalan D Nair; Aaron K Wong; Arjun Krishnan; Olga G Troyanskaya; Deborah Raymond; Rachel Saunders-Pullman; Susan B Bressman; Zhenyu Yue; Stuart C Sealfon
Journal:  Mov Disord       Date:  2015-03-18       Impact factor: 10.338

Review 4.  Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Authors:  Masayuki Nakamori; Eunsung Junn; Hideki Mochizuki; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

5.  Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.

Authors:  Jian Zhang; Mei Hu; Zhaoqian Teng; Ya-Ping Tang; Chu Chen
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

Review 6.  Genetic determinants of neuronal vulnerability to apoptosis.

Authors:  Angeles Almeida
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

7.  Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis.

Authors:  Tamara Ratovitski; Ekaterine Chighladze; Nicolas Arbez; Tatiana Boronina; Shelley Herbrich; Robert N Cole; Christopher A Ross
Journal:  Cell Cycle       Date:  2012-05-15       Impact factor: 4.534

8.  MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain.

Authors:  Jie Zhang; Mengyuan Zhao; Run Yan; Jun Liu; Santhosh Maddila; Eunsung Junn; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2021-10-25       Impact factor: 6.088

9.  Paraquat and MPTP induce neurodegeneration and alteration in the expression profile of microRNAs: the role of transcription factor Nrf2.

Authors:  Qingqing Wang; Nan Ren; Zhipeng Cai; Qingxia Lin; Zhangjing Wang; Qunwei Zhang; Siying Wu; Huangyuan Li
Journal:  NPJ Parkinsons Dis       Date:  2017-10-20

10.  The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress.

Authors:  Stephanie E Oh; Hye-Jin Park; Liqiang He; Catherine Skibiel; Eunsung Junn; M Maral Mouradian
Journal:  Redox Biol       Date:  2018-08-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.